Victory Capital Management
ALNA

Victory Capital Management’s Allena Pharmaceuticals ALNA Stock Holding History

Victory Capital Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,745
Closed -$2K – 2774
2022
Q1 		$2K Sell
10,745
-306
-3% -$127 ﹤0.01% 2722
2021
Q4 		$7K Sell
11,051
-9
-0.1% -$7 ﹤0.01% 2752
2021
Q3 		$10K Buy
+11,060
New +$10.8K ﹤0.01% 2762
2020
Q2 		– Sell
-4,682
Closed -$4K – 3554
2020
Q1 		$4K Buy
+4,682
New +$9.37K ﹤0.01% 3585
2019
Q4 		– Sell
-1,815
Closed -$7K – 3536
2019
Q3 		$7K Buy
+1,815
New +$7.79K ﹤0.01% 3381

Other funds holding ALNA

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Victory Capital Management's ALNA Position: Q2 2022 in Review

Victory Capital Management sold out of Allena Pharmaceuticals (ALNA) in Q2 2022, closing a stake of 10,745 shares — an estimated $2K sold.

Victory Capital Management first reported a position in ALNA in Q3 2019 and held it in 5 quarters. The position peaked at $10K in Q3 2021. 25 funds tracked by Wall St. Rank hold ALNA as of Q2 2022.

  • Victory Capital Management reported no remaining Allena Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Victory Capital Management sold 10,745 Allena Pharmaceuticals shares in Q2 2022, an estimated $2K.
  • Victory Capital Management first reported a position in Allena Pharmaceuticals in Q3 2019 and held it in 5 quarters.
  • Victory Capital Management's Allena Pharmaceuticals position peaked at $10K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2022.

Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.